UNRESECTABLE HEPATOCELLULAR CARCINOMA
Clinical trials for UNRESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo for liver cancer passes safety check in 1,200 patients
Disease control CompletedThis study looked at the safety of two drugs, IMJUDO and IMFINZI, given together or alone to 1,200 people with advanced liver cancer that cannot be removed by surgery. The goal was to track any side effects that happen in real-world use. The study is now complete, and the results…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New injection shows promise for untreatable liver cancer
Disease control CompletedThis early-stage study tested a new drug called NRT6003 in 40 adults with liver cancer that cannot be surgically removed. The main goals were to check for side effects and see if the injection shrinks tumors in the liver. Researchers also measured how long the tumors stayed contr…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Chengdu New Radiomedicine Technology Co. LTD. • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
New PET scan could sharpen view of advanced liver cancer
Diagnosis CompletedThis study tested whether a special PET scan using a radioactive tracer (68Ga-PSMA) can improve how doctors see and manage advanced liver cancer that has spread. The tracer attaches to a protein found on liver cancer cells, making them show up on the scan. 29 adults with advanced…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 15, 2026 11:57 UTC